Patent ID: 11873337
Assignee: KAGOSHIMA UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C

Claim 3:
4. The antibody or the antibody fragment thereof according to claim 1, wherein the antibody or the antibody fragment thereof is selected from the group consisting of the following (1) to (30):
(1) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 22 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 27;
(2) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 32 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 37;
(3) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 2;
(4) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 7;
(5) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 12;
(6) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 17;
(7) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 68;
(8) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 70;
(9) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 72;
(10) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 74;
(11) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 76;
(12) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 78;
(13) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 80;
(14) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 82;
(15) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 84;
(16) an antibody fragment in which the amino acid sequence of VHH comprises the amino acid sequence represented by SEQ ID NO: 86;
(17) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 88 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 93;
(18) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 98 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(19) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 103 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(20) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 108 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(21) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 113 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(22) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 118 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(23) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 123 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(24) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 128 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 133;
(25) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 138 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 163;
(26) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 143 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 163;
(27) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 148 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 163;
(28) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 153 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 163;
(29) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 158 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 163; and
(30) an antibody in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 168 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 173.